Holdings of Health Sciences Trust
John Hancock Variable Insurance Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 227.2M $ including 225M $ in equities, 99.0 %
- Positions
- 170 in 13 countries
- Top ten
- 40.0 % of net assets
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Eli Lilly & Co | 25,208 | 23.2M $ | 10.20 % |
| 2 | Thermo Fisher Scientific Inc | 19,052 | 9.4M $ | 4.12 % |
| 3 | Intuitive Surgical Inc | 18,275 | 8.4M $ | 3.71 % |
| 4 | Stryker Corp | 24,345 | 8M $ | 3.52 % |
| 5 | Merck & Co Inc | 65,688 | 7.9M $ | 3.48 % |
| 6 | AstraZeneca PLC | 37,129 | 7.3M $ | 3.22 % |
| 7 | UnitedHealth Group Inc | 26,309 | 7.1M $ | 3.13 % |
| 8 | Argenx SE | 9,314 | 6.8M $ | 2.99 % |
| 9 | AbbVie Inc | 30,125 | 6.6M $ | 2.88 % |
| 10 | Regeneron Pharmaceuticals, Inc. | 7,905 | 6.1M $ | 2.69 % |
| 11 | Gilead Sciences Inc | 43,100 | 6M $ | 2.64 % |
| 12 | Johnson & Johnson | 22,972 | 5.6M $ | 2.47 % |
| 13 | Vertex Pharmaceuticals Inc | 12,528 | 5.6M $ | 2.46 % |
| 14 | Danaher Corp | 24,964 | 4.7M $ | 2.08 % |
| 15 | Alnylam Pharmaceuticals Inc | 11,541 | 3.8M $ | 1.68 % |
| 16 | Ascendis Pharma A/S | 14,430 | 3.3M $ | 1.45 % |
| 17 | United Therapeutics Corp | 5,491 | 3.3M $ | 1.43 % |
| 18 | Revolution Medicines Inc | 32,474 | 3.2M $ | 1.39 % |
| 19 | BeOne Medicines Ltd | 124,598 | 2.8M $ | 1.23 % |
| 20 | Protagonist Therapeutics Inc | 25,165 | 2.7M $ | 1.17 % |
| 21 | Roivant Sciences Ltd | 95,284 | 2.6M $ | 1.16 % |
| 22 | Insmed Inc | 15,382 | 2.5M $ | 1.11 % |
| 23 | Summit Therapeutics Inc | 131,177 | 2.5M $ | 1.09 % |
| 24 | Natera Inc | 12,057 | 2.4M $ | 1.06 % |
| 25 | Tenet Healthcare Corp | 12,442 | 2.3M $ | 1.03 % |
| 26 | Amgen Inc | 6,637 | 2.3M $ | 1.03 % |
| 27 | BrightSpring Health Services Inc | 54,000 | 2.3M $ | 1.01 % |
| 28 | Boston Scientific Corp | 34,293 | 2.2M $ | 0.95 % |
| 29 | HCA Healthcare Inc | 4,436 | 2.1M $ | 0.92 % |
| 30 | Guardant Health Inc | 22,713 | 2.1M $ | 0.92 % |
| 31 | CVS Health Corp | 28,410 | 2M $ | 0.90 % |
| 32 | Kymera Therapeutics Inc | 22,089 | 1.8M $ | 0.81 % |
| 33 | Cigna Group/The | 6,670 | 1.8M $ | 0.78 % |
| 34 | CG oncology Inc | 24,056 | 1.6M $ | 0.72 % |
| 35 | Cardinal Health, Inc. | 7,652 | 1.6M $ | 0.71 % |
| 36 | Elevance Health Inc | 5,292 | 1.5M $ | 0.68 % |
| 37 | Krystal Biotech Inc | 5,944 | 1.5M $ | 0.68 % |
| 38 | Scholar Rock Holding Corp | 29,902 | 1.5M $ | 0.65 % |
| 39 | Bridgebio Pharma Inc | 19,531 | 1.5M $ | 0.64 % |
| 40 | Ionis Pharmaceuticals Inc | 19,249 | 1.4M $ | 0.64 % |
| 41 | Chugai Pharmaceutical Co Ltd | 25,000 | 1.4M $ | 0.61 % |
| 42 | Praxis Precision Medicines Inc | 4,271 | 1.4M $ | 0.61 % |
| 43 | Structure Therapeutics Inc | 28,241 | 1.4M $ | 0.60 % |
| 44 | Celcuity Inc | 11,819 | 1.3M $ | 0.59 % |
| 45 | Royalty Pharma PLC | 27,659 | 1.3M $ | 0.58 % |
| 46 | CENTESSA PHARMACEUTICALS PLC | 31,457 | 1.2M $ | 0.55 % |
| 47 | Cencora Inc | 3,935 | 1.2M $ | 0.54 % |
| 48 | Vera Therapeutics Inc | 27,378 | 1.1M $ | 0.48 % |
| 49 | Nuvalent Inc | 10,208 | 1M $ | 0.46 % |
| 50 | Apogee Therapeutics Inc | 12,307 | 1M $ | 0.46 % |
| 51 | Edwards Lifesciences Corp | 12,785 | 1M $ | 0.45 % |
| 52 | Incyte Corp | 10,734 | 1M $ | 0.44 % |
| 53 | Abivax SA | 9,016 | 1M $ | 0.44 % |
| 54 | Spyre Therapeutics Inc | 19,484 | 982.8K $ | 0.43 % |
| 55 | Cytokinetics Inc | 14,740 | 971.5K $ | 0.43 % |
| 56 | Dianthus Therapeutics Inc | 11,216 | 941.2K $ | 0.41 % |
| 57 | Crinetics Pharmaceuticals Inc | 25,378 | 921.7K $ | 0.41 % |
| 58 | Madrigal Pharmaceuticals Inc | 1,671 | 874.7K $ | 0.39 % |
| 59 | Immunome Inc | 39,589 | 865.8K $ | 0.38 % |
| 60 | IQVIA Holdings Inc | 4,791 | 817.1K $ | 0.36 % |
| 61 | Kodiak Sciences Inc | 21,314 | 812.5K $ | 0.36 % |
| 62 | Belite Bio Inc | 4,800 | 765.3K $ | 0.34 % |
| 63 | Monte Rosa Therapeutics Inc | 45,126 | 742.3K $ | 0.33 % |
| 64 | Terns Pharmaceuticals Inc | 13,841 | 729.7K $ | 0.32 % |
| 65 | Mirum Pharmaceuticals Inc | 7,430 | 686.4K $ | 0.30 % |
| 66 | Axsome Therapeutics Inc | 3,961 | 669.5K $ | 0.29 % |
| 67 | Moderna Inc | 12,539 | 637K $ | 0.28 % |
| 68 | Alignment Healthcare Inc | 34,394 | 606K $ | 0.27 % |
| 69 | Beam Therapeutics Inc | 25,010 | 596K $ | 0.26 % |
| 70 | Alumis Inc | 26,808 | 590.6K $ | 0.26 % |
| 71 | IDEXX Laboratories Inc | 1,028 | 577.6K $ | 0.25 % |
| 72 | Revvity Inc | 6,470 | 566.8K $ | 0.25 % |
| 73 | Sionna Therapeutics Inc | 14,085 | 564.7K $ | 0.25 % |
| 74 | Sonova Holding AG | 2,403 | 547.9K $ | 0.24 % |
| 75 | MBX Biosciences Inc | 17,761 | 530.2K $ | 0.23 % |
| 76 | West Pharmaceutical Services Inc | 2,100 | 526.3K $ | 0.23 % |
| 77 | McKesson Corp | 608 | 526.1K $ | 0.23 % |
| 78 | ORIC Pharmaceuticals Inc | 41,012 | 519.6K $ | 0.23 % |
| 79 | Rhythm Pharmaceuticals Inc | 5,825 | 506.6K $ | 0.22 % |
| 80 | Immunocore Holdings PLC | 16,454 | 496.1K $ | 0.22 % |
| 81 | Rapport Therapeutics Inc | 15,736 | 492.4K $ | 0.22 % |
| 82 | Arrowhead Pharmaceuticals Inc | 7,841 | 491.6K $ | 0.22 % |
| 83 | Nurix Therapeutics Inc | 31,364 | 486.1K $ | 0.21 % |
| 84 | Caris Life Sciences Inc | 26,832 | 479.8K $ | 0.21 % |
| 85 | Erasca Inc | 28,600 | 462.7K $ | 0.20 % |
| 86 | Oruka Therapeutics Inc | 9,120 | 447.3K $ | 0.20 % |
| 87 | Billiontoone Inc | 5,603 | 442.3K $ | 0.19 % |
| 88 | Centene Corp | 13,351 | 437.1K $ | 0.19 % |
| 89 | Vaxcyte Inc | 7,498 | 435.7K $ | 0.19 % |
| 90 | Bio-Rad Laboratories Inc | 1,537 | 428.4K $ | 0.19 % |
| 91 | Palvella Therapeutics Inc | 3,373 | 420.4K $ | 0.19 % |
| 92 | MoonLake Immunotherapeutics | 21,385 | 398.6K $ | 0.18 % |
| 93 | Encompass Health Corp | 3,941 | 381.2K $ | 0.17 % |
| 94 | Relay Therapeutics Inc | 36,491 | 363.1K $ | 0.16 % |
| 95 | BEONE MEDICINES LTD | 1,214 | 360.5K $ | 0.16 % |
| 96 | Kestra Medical Technologies Ltd | 17,599 | 350.7K $ | 0.15 % |
| 97 | WaVe Life Sciences Ltd | 47,883 | 347.2K $ | 0.15 % |
| 98 | Charles River Laboratories International Inc | 2,002 | 345.3K $ | 0.15 % |
| 99 | Repligen Corp | 2,923 | 344.4K $ | 0.15 % |
| 100 | Bicara Therapeutics Inc | 17,135 | 340.8K $ | 0.15 % |
Sector breakdown
- Health care 66.3 %
- Unattributed 33.7 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 97.8 %
- HKD 1.2 %
- JPY 0.6 %
- CHF 0.2 %
- EUR 0.1 %
The quoted currency of each line, as declared.
Country breakdown
- United States 87.0 %
- United Kingdom 3.3 %
- Netherlands 3.2 %
- Denmark 1.6 %
- Bermuda 1.3 %
- Hong Kong SAR China 1.2 %
- Japan 0.6 %
- Cayman Islands 0.6 %
- France 0.5 %
- Switzerland 0.2 %
- Singapore 0.2 %
- British Virgin Islands 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 149 | 195.8M $ | 87.04 % |
| 2 | United Kingdom | 2 | 7.4M $ | 3.31 % |
| 3 | Netherlands | 3 | 7.2M $ | 3.20 % |
| 4 | Denmark | 2 | 3.6M $ | 1.62 % |
| 5 | Bermuda | 2 | 3M $ | 1.33 % |
| 6 | Hong Kong SAR China | 1 | 2.8M $ | 1.24 % |
| 7 | Japan | 1 | 1.4M $ | 0.61 % |
| 8 | Cayman Islands | 4 | 1.4M $ | 0.60 % |
| 9 | France | 2 | 1.2M $ | 0.52 % |
| 10 | Switzerland | 1 | 547.9K $ | 0.24 % |
| 11 | Singapore | 1 | 347.2K $ | 0.15 % |
| 12 | British Virgin Islands | 1 | 266.6K $ | 0.12 % |
Cite this page
Titelia. "Holdings of Health Sciences Trust". https://titelia.com/en/funds/S000008239